Dendritic Cells/Natural Killer Cross-Talk: A Novel Target for Human Immunodeficiency Virus Type-1 Protease Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dendritic Cells/Natural Killer Cross-Talk: A Novel Target for Human Immunodeficiency Virus Type-1 Protease Inhibitors

Published:2010-06-10 Issue:6 Volume:5 Page:e11052
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Giardino Torchia Maria Letizia,Ciaglia Elena,Masci Anna Maria,Vitiello Laura,Fogli Manuela,la Sala Andrea,Mavilio Domenico,Racioppi Luigi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors.;A Mastrolorenzo;Curr Med Chem,2007

2. Aspartic peptidase inhibitors: implications in drug development.;C Dash;Crit Rev Biochem Mol Biol,2003

3. Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss.;BN Phenix;Blood,2001

4. HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells.;FF Weichold;J Hum Virol,1999

5. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.;P Andre;Proc Natl Acad Sci U S A,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir;Cancers;2020-11-19

2. Butyrate as a bioactive human milk protective component against food allergy;Allergy;2020-11-16

3. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome;International Reviews of Immunology;2020-11-16

4. Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies (Review);Oncology Reports;2020-03-26

5. Editorial - HCC in HCV patients and the direct acting antivirals: is there really a link?;EUR REV MED PHARMACO;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3